Research
Energy balance
SGLT2 inhibitors improve mitochondrial function and reduce oxidative stress, contributing to their cardioprotective and renoprotective effects.
SGLT2 inhibitors may help your cells produce energy more efficiently and reduce cellular stress, which protects your heart and kidneys. This is part of why these drugs work beyond just lowering blood sugar.
GoodSupportsHIGH confidence
Experimental animal studies have shown that SGLT2is reduce ROS production, decrease mitochondrial fragmentation, balance mitochondrial fusion and fission, enhance mitochondrial respiratory function, stimulate mitochondrial biogenesis, and regulate intracellular calcium handling, collectively contributing to normal cellular processes and the reversal of CRM syndrome
Why this rating
Supported by experimental animal studies and cell cultures, with emerging evidence in humans, but less direct clinical outcome data than N1.
Source
SGLT2 Inhibitors in the Management of Cardio-Renal-Metabolic Syndrome: A New Therapeutic Era
Konstantinos Grigoriou et al. · Medicina · 2025
DOI 10.3390/medicina61111903
narrative_reviewCited 3×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- SGLT2 inhibitors reduce cardiovascular death, heart failure hospitalizations, and kidney disease progression in patients with cardio-renal-metabolic syndrome, regardless of diabetes status.Strong
- SGLT2 inhibitors reduce body weight and blood pressure, contributing to their overall benefit in CRM syndrome.Good
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →